- Home
- XNCR vs OPK Comparison
XNCR vs OPK Comparison
Compare XNCR & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- OPK
- Stock Information
- Founded
- XNCR 1997
- OPK 2007
- Country
- XNCR United States
- OPK United States
- Employees
- XNCR N/A
- OPK N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- XNCR Health Care
- OPK Health Care
- Exchange
- XNCR Nasdaq
- OPK Nasdaq
- Market Cap
- XNCR 1.1B
- OPK 1.1B
- IPO Year
- XNCR 2013
- OPK 1995
- Fundamental
- Price
- XNCR $13.86
- OPK $1.35
- Analyst Decision
- XNCR Buy
- OPK Buy
- Analyst Count
- XNCR 11
- OPK 4
- Target Price
- XNCR $23.50
- OPK $2.28
- AVG Volume (30 Days)
- XNCR 1.5M
- OPK 2.0M
- Earning Date
- XNCR 11-05-2025
- OPK 10-29-2025
- Dividend Yield
- XNCR N/A
- OPK N/A
- EPS Growth
- XNCR N/A
- OPK N/A
- EPS
- XNCR N/A
- OPK N/A
- Revenue
- XNCR $150,132,000.00
- OPK $642,067,000.00
- Revenue This Year
- XNCR $22.09
- OPK N/A
- Revenue Next Year
- XNCR N/A
- OPK N/A
- P/E Ratio
- XNCR N/A
- OPK N/A
- Revenue Growth
- XNCR 38.16
- OPK N/A
- 52 Week Low
- XNCR $6.92
- OPK $1.11
- 52 Week High
- XNCR $27.24
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- XNCR 54.01
- OPK 37.88
- Support Level
- XNCR $13.30
- OPK $1.30
- Resistance Level
- XNCR $15.16
- OPK $1.43
- Average True Range (ATR)
- XNCR 1.14
- OPK 0.06
- MACD
- XNCR -0.18
- OPK -0.02
- Stochastic Oscillator
- XNCR 50.22
- OPK 18.75
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.